What PARI does

PARI is a German-founded (1906) manufacturer of medical compression nebulizer inhalation systems, with proprietary nebulizer cup technology that has positioned the brand as a clinical standard in respiratory drug delivery. Its product portfolio spans compressor machines across the Classic Series (PARI BOY CLASSIC, PARI BOY Junior for pediatric patients aged 0-12, PARI BOY Pro for severe COPD), the SINUS line (PARI SINUS 2 and SINUS N with pulse oscillation technology targeting nasal sinus deposition of ~12.5%, approximately 28x higher than traditional nasal sprays), the Comfort Series (INQUAir, COMPACT2, UNINEB for entry-level home use), and a cross-compatible nebulizer cup ecosystem (PARI LC SPRINT with five color-coded nozzle variants, PARI LC Plus as the reusable gold-standard cup, and PARI LCD disposable cups for hospital single-patient use). Underlying technical differentiators include unidirectional valve guidance, PIF (Peak Inspiratory Flow) control with tactile feedback for correct inhalation speed, secondary particle screening that deflects oversized particles back into the reservoir, and a respiratory interrupter for cough-management; product performance is validated under the ISO27427 standard using cascade impactor and respiratory simulator testing.

In China, all sales and after-sales service are operated exclusively by Beijing Haidi Ousheng Trading Co., Ltd., a private Chinese distributor established around 2015. Revenue mechanics rely on one-time hardware sales (compressors and reusable cups) plus a recurring consumables tail driven by annual reusable-cup replacement and 15-day LCD disposable-cup replacement cycles. Go-to-market is multi-channel: JD.com and Tmall self-operated flagships, 50+ authorized online dealers across Pinduoduo/Douyin/Xiaohongshu, 20+ province offline dealer network, and designated south/north regional sales managers. Customer acquisition combines professional medical education (CME conferences, webinars with Peking University Third Hospital and Shanghai Jiao Tong University experts, GINA/ERS guideline references) with consumer-facing pediatric and respiratory-disease education content and social-commerce trade-in campaigns on Xiaohongshu. End customers are fragmented households and individual patients across asthma, COPD, sinusitis, allergic rhinitis, and pediatric respiratory infections, while enterprise users include hospital respiratory/pediatric/ENT departments using PARI LCD disposable cups.

Name

PARI

Legal name

Beijing HaiDi Ousheng Commercial and Trading Co., Ltd. (北京海迪欧胜商贸有限公司)

Website

https://breath-easy.com

Company type

Private

Founded year

1906

Operating status

Operating

Headcount range

11–50 employees

Short description

PARI is a German-founded (1906) manufacturer of medical compression nebulizer systems for asthma, COPD, sinusitis, and pediatric respiratory conditions, sold in China exclusively through distributor Beijing Haidi Ousheng Trading Co. across e-commerce, social commerce, and a 20+-province offline dealer network.

Ownership category

akta.pro rank

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Nebulizer Hardware Sales (Compressors + Nebulizer Cups): PARI generates revenue primarily through the sale of compression nebulizer machines (compressors) and their companion nebulizer cups/atomizers. The product line is segmented across comfort/economy series (INQUAir, COMPACT2), classic/pro series (BOY, SINUS), and accessories (masks, mouthpieces, tubing). Nebulizer cups are sold both as durable reusable units (replaced annually) and disposable single-patient-use units (replaced every 15 days for LCD series). Revenue is one-time at point of sale with a consumables/ accessories replenishment cycle.
2. Aftermarket Accessories and Consumables: Replacement nebulizer cups, masks, mouthpieces, connecting tubes, and nasal irrigation accessories constitute a recurring consumables revenue stream. PARI recommends annual replacement of reusable nebulizer cups and 15-day replacement cycles for LCD disposable cups, creating a recurring revenue relationship with customers.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

PARI is a German manufacturer of medical compression nebulizer inhalation systems that convert liquid medication into respirable aerosol particles for the treatment of respiratory conditions such as asthma, bronchitis, cystic fibrosis, and sinus disorders. The company designs and sells compressor-based nebulizer units (PARI BOY and PARI SINUS series) together with proprietary nebulizer cups (PARI LC SPRINT, LC Plus, LCD) and accessories, and distributes these products in China exclusively through Beijing HaiDi Ousheng Commercial and Trading Co., Ltd. (北京海迪欧盛商贸有限公司) for both clinical and home-care use.

Product overview

PARI is a German manufacturer of medical compression nebulizer systems founded in 1906, producing a portfolio of compressor-based nebulizers, reusable and disposable nebulizer cups, and respiratory accessories. The core portfolio is organized into five product lines: (1) Classic Series — PARI BOY CLASSIC, PARI BOY Junior (pediatric-specific, launched 2011 with yellow chassis), PARI BOY Pro (adjustable droplet size with interchangeable nozzles for severe COPD), PARI SINUS 2, and PARI SINUS N (both pulsating oscillation nebulizers for sinusitis using different sinus penetration technologies); (2) Comfort Series — INQUAir Blue Spa (German-manufactured with LC SPRINT SPA), INQUAir Green Spa (cost-effective with LC PLUS cup), PARI COMPACT2 Junior (economical pediatric), PARI COMPACT2 Pro (economical adult COPD), and UNINEB (entry-level with LC PLUS); (3) Nebulizer Cup Series — PARI LC SPRINT (reusable with five nozzle color variants: blue/yellow/red/XLent/orange), PARI LC Plus (reusable gold standard), and PARI LCD (disposable hospital-grade); (4) PARI HEALTH Series — disposable LCD nebulizer cups, nasal irrigation devices, and oral/nasal aerosol delivery chambers for home and clinical care; (5) PARI Machine History — legacy models including PARI TurboBOY and PARI JuniorBOY. Accessories include infant masks, adult masks, elbow tubes, mouth pieces, and inhalation intermittent devices. The ecosystem is unified by cross-compatible PARI LC SPRINT and PARI LC PLUS nebulizer cups that work across all PARI compressor models.

Differentiator

Problem solved

Functional benefit

Brands

• PARI BOY: PARI BOY series compressor nebulizer inhalation machines for treating respiratory diseases such as asthma and bronchitis across all age groups.
• PARI JuniorBOY
• PARI SINUS 2
• PARI LC SPRINT
• PARI LC Plus
• INQUAir Green Spa
• INQUAir Blue Spa

Products and services

• PARI BOY series compression nebulizer system Compressor-based nebulizer unit that converts liquid medication into respirable aerosol particles for the treatment of respiratory conditions such as asthma, bronchitis, and cystic fibrosis in home and clinical settings.
• PARI SINUS series compression nebulizer system Compressor-based nebulizer unit designed to deliver aerosolized medication to the sinus and upper-airway region for the treatment of sinus and related upper-respiratory conditions in home and clinical settings.
• PARI LC SPRINT nebulizer cup Proprietary nebulizer cup accessory that attaches to PARI compressor units to generate aerosol particles optimized for respiratory drug delivery; intended as a recurring replacement consumable for home and clinical users.
• PARI LC Plus nebulizer cup Proprietary nebulizer cup accessory for PARI compressor units, engineered to produce a defined aerosol particle spectrum for inhalation therapy; sold as a recurring replacement consumable for home and clinical users.
• PARI LCD nebulizer cup Proprietary nebulizer cup accessory for PARI compressor units, designed to support controlled aerosol drug delivery during inhalation therapy; sold as a recurring replacement consumable for home and clinical users.

Quantifiable outcome

• MMD 2.2 µm (red nozzle, for severe COPD and deep lung deposition)
• +6 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• ResMed: Global leader in sleep apnea and respiratory care with a broader portfolio spanning CPAP, ventilators, and connected respiratory devices. Overlaps with PARI in clinical respiratory care but focuses more on sleep-disordered breathing than nebulized drug delivery.
• Fisher & Paykel Healthcare: New Zealand-based manufacturer of respiratory care products including humidification systems, CPAP interfaces, and hospital respiratory equipment. Operates as a broader respiratory care incumbent with overlapping hospital customer base in pulmonology and neonatology.

Direct peers

• Philips Respironics: Division of Philips offering home respiratory care products including the InnoSpire series of compressor nebulizers. Directly competes with PARI in hospital and home nebulization across global markets including China, with comparable proprietary nebulizer cup systems.
• Rossmax International: Taiwanese manufacturer of home medical devices including the NE100 and NE200 series compressor nebulizers. Competes with PARI across Asian markets with comparable clinical-grade positioning and similar distribution through pharmacy and e-commerce channels.
• Yuwell Medical (鱼跃医疗): China's leading home medical device manufacturer (publicly listed) with a major nebulizer product line (e.g., 405M, 403M series). Most comparable Chinese competitor to PARI in the home-use segment, with strong distribution in pharmacies and e-commerce channels across China.
• Drive DeVilbiss Healthcare: US-based manufacturer of respiratory care products including the PulmoNeb and Pulmo-Aide compressor nebulizers. Directly competes with PARI's PARI BOY line in clinical and home nebulization markets globally.
• BMC Medical: Chinese medical device company specializing in respiratory and sleep therapy products, including nebulizers and ventilators. Emerging direct competitor to PARI in China's hospital and home respiratory care segments, with growing domestic brand recognition.
• A&D Medical: Japanese manufacturer of home healthcare and medical devices including nebulizer products. Comparable to PARI in engineering pedigree, Asian market presence, and focus on clinically validated home-use respiratory equipment.
• Omron Healthcare: Japanese manufacturer of home medical devices with a major nebulizer product line (e.g., NE-C28, NE-C803) competing directly against PARI in compression nebulizers across Asia and globally. Strong retail presence in Chinese pharmacies and e-commerce, making it the most directly comparable peer.

Regional players

• Beurer: German manufacturer of home health and wellness products including compressor nebulizers (e.g., IH21, IH40). Comparable German engineering pedigree to PARI and similar brand positioning in European home medical device market, but with limited China presence compared to PARI's exclusive distributor model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/breath-easy-trading-co-ltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PARI